McGrath Lynne Fahey
Director at ALZN
- Sold, on record
- $69
- Dollars the filings state
- Form 4 sales
- 1
- Latest Oct 23, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ALZNAlzamend Neuro, Inc.Director
Sales by reason
0
Routine
0
Plan not stated
0
No plan
1
Unusual
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 4 sale ALZNUnusualOct 23, 2025 2025
Sold 30 shares at $2.29 ($69)
McGrath Lynne Fahey, Director
No 10b5-1 planSold 54.5% of holdings ($126 position)25 shares leftFirst sale on recordFiling
Every transaction
Loading transactions…